These rates can not be beat
by any other program in many cases so you're able to get bargains left and right.
Not exact matches
Important factors that could cause actual results to differ materially from those reflected
in such forward - looking statements and that should be considered
in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing
programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development
programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787
program; 4) margin pressures and the potential for additional forward losses on new and maturing
programs; 5) our ability to accommodate, and the cost of accommodating, announced increases
in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest
in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions
in the industries and markets
in which we operate
in the U.S. and globally and any changes therein, including fluctuations
in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain
in a timely fashion any required regulatory or
other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our
other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and
other customers, and the risk of nonpayment
by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders
by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or
other security attacks, information technology failures, or
other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and
other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both
in the U.S. and abroad; 20) the effect of changes
in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction
in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending
by the U.S. and
other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging
programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and
other cost savings; 32) our ability to consummate our announced acquisition of Asco
in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and
other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing
program; 34) the risks of doing business internationally, including fluctuations
in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among
other things.
By keeping interest rates artificially low, through a program called quantitative easing, the central bank tried to mitigate the negative effects of the recession by promoting investment in other asset classe
By keeping interest rates artificially low, through a
program called quantitative easing, the central bank tried to mitigate the negative effects of the recession
by promoting investment in other asset classe
by promoting investment
in other asset classes.
An infographic
by USF's online mpa
program has showcased the rapid evolution going on
in twitter, and
other social media.
ENJOINED AND RESTRAINED from,
in any manner or
by any means, removing individuals with refugee applications approved
by U.S. Citizenship and Immigration Services as part of the U.S. Refugee Admissions
Program, holders of valid immigrant and non-immigrant visas, and
other individuals from Iraq, Syria, Iran, Sudan, Libya, Somalia, and Yemen legally authorized to enter the United States.
Dozens of
other loan
programs — including the 504 Certified Development Loan
Program, which is accessed
by small - business owners for loans to buy large fixed assets and real estate — and many mentorship
programs, including the SCORE system and Veteran's Business Development offices, would be shuttered
in the case of a government shutdown.
Use of Name and Likeness:
By posting User Content on the online services, you consent to the recording, use and reuse by NBCUniversal, its licensees, successors and assigns, of your voice, actions, likeness, name, appearance, profile photograph, performance, biographical material, and any other identifying information, including, without limitation, any information contained in your User Content (collectively, «Personal Elements»), as used, edited, altered, fictionalized or modified by NBCUniversal, in its sole discretion, in any and all media now known or hereafter devised, throughout the world, in perpetuity, including, without limitation, in and in connection with NBCUniversal, or related Sites or online services, in and in connection with any television programs and other productions, and in and in connection with advertising, promotion and publicit
By posting User Content on the online services, you consent to the recording, use and reuse
by NBCUniversal, its licensees, successors and assigns, of your voice, actions, likeness, name, appearance, profile photograph, performance, biographical material, and any other identifying information, including, without limitation, any information contained in your User Content (collectively, «Personal Elements»), as used, edited, altered, fictionalized or modified by NBCUniversal, in its sole discretion, in any and all media now known or hereafter devised, throughout the world, in perpetuity, including, without limitation, in and in connection with NBCUniversal, or related Sites or online services, in and in connection with any television programs and other productions, and in and in connection with advertising, promotion and publicit
by NBCUniversal, its licensees, successors and assigns, of your voice, actions, likeness, name, appearance, profile photograph, performance, biographical material, and any
other identifying information, including, without limitation, any information contained
in your User Content (collectively, «Personal Elements»), as used, edited, altered, fictionalized or modified
by NBCUniversal, in its sole discretion, in any and all media now known or hereafter devised, throughout the world, in perpetuity, including, without limitation, in and in connection with NBCUniversal, or related Sites or online services, in and in connection with any television programs and other productions, and in and in connection with advertising, promotion and publicit
by NBCUniversal,
in its sole discretion,
in any and all media now known or hereafter devised, throughout the world,
in perpetuity, including, without limitation,
in and
in connection with NBCUniversal, or related Sites or online services,
in and
in connection with any television
programs and
other productions, and
in and
in connection with advertising, promotion and publicity.
Programmed Maintenance Services has flagged a $ 75 million impairment resulting from poor performance
in its marine services division, but expects to lift earnings to over $ 100 million
by FY17 as it benefits from growth
in other sectors of the economy.
The
program, founded
by Paul Graham, Jessica Livingston and
others back
in 2005, is known for giving seed money and 3 - month boot campsto top tech startups.
By exploiting a flaw
in Apple's Fairplay software that prevents purchased apps from being used on non-authorized devices, the bogus
program scans the App Store for
other corrupted apps
in the AceDeceiver family and downloads the software to the device.
Other than making vague promises to place more police officers on the streets, encouraging DNA testing for death - row inmates and calling for the need to reduce recidivism
by investing
in «proven community - based law - enforcement
programs,» the Democrats» policy solutions over the past eight years have done little to dismantle the carceral state that they helped create.
A computer virus is an instance of malware that, when executed, replicates itself
by inserting its own code into data files (often
in the form of rogue macros), «boot sectors» of hard drives or SSDs, or
other computer
programs.
Teletubbies is still wildly popular on YouTube where DHX estimates that episodes and clips of the
program received about 40 million views worldwide
in May through both its official channel and videos posted
by other users.
Former Harvard president Larry Summers called the
program «the single most misdirected philanthropy
in this decade,» according to TechCrunch, while Slate Group chairman Jacob Weisberg wrote
in Newsweek, «Thiel fellows will have the opportunity to emulate their sponsor
by halting their intellectual development around the onset of adulthood, maintaining a narrow - minded focus on getting rich as young as possible and thereby avoid the siren lure of helping
others or pursuing knowledge for its own sake.»
When Salesforce (CRM) plunked down $ 212 million to buy Heroku five years ago, it got a very popular software development site beloved
by startups who
programmed in Ruby (and later
other languages).
In a new poll conducted
by Morning Consult for Fortune, nearly two - thirds of millennials say they prefer companies that make cash contributions to charity or have
other philanthropic
programs.
A major investment
by Stanford University
in StartX places it ahead of
other university accelerator
programs — but the free - flowing funds also renew questions about a school's role
in incubating the next big thing.
As the kinds of graphics chips that were first popular with video gamers have turned out to be among the best - suited for AI
programming, too, Nvidia is
in the lead, chased
by Intel (intc), Advanced Micro Devices, and a host of
others.
But the episode brings new attention to the fragile nature of popular software
programs, and the way
in which they are exploited
by spy agencies and
others.
In order to make the
program work with a wide range of Web technologies, Microsoft had made it easy for website developers to get access to the guts of the
program while it ran on a user's machine — which meant the IE user's software could also be exploited
by hackers, spammers, and
other unscrupulous Web bottom feeders.
These executives» frustrations are reflected
in the results of a new study
by McKinsey & Co. that shows that only 42 % of employers believe new graduates
in the workforce are adequately prepared
by their colleges or
other pre-employment training
programs.
«Besides looking at a top - down strategy to recognize the power of design
in organizations, the
other side is to encourage a bottom - up look
by promoting educational and traditional design craft, and introducing design thinking into engineering or MBA
programs, where people don't think of themselves as designers
in the traditional sense of the word,» said Hayes.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth
in revenues for its antiviral and
other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures
in European countries that may increase the amount of discount required on Gilead's products; an increase
in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift
in payer mix to more highly discounted payer segments and geographic regions and decreases
in treatment duration; availability of funding for state AIDS Drug Assistance
Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
Programs (ADAPs); continued fluctuations
in ADAP purchases driven
by federal and state grant cycles which may not mirror patient demand and may cause fluctuations
in Gilead's earnings; market share and price erosion caused
by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or
other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials
in its currently anticipated timeframes; the levels of inventory held
by wholesalers and retailers which may cause fluctuations
in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates
in the timelines currently anticipated; Gilead's ability to receive regulatory approvals
in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over
other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory
programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (t
programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta
in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase
program due to changes
in its stock price, corporate or
other market conditions; fluctuations
in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and
other risks identified from time to time
in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
A total of 138 public libraries and
other locations
in seven states — Alaska, Florida, Iowa, Kentucky, Ohio, Pennsylvania, Wyoming — and the District of Columbia took part
in the 2017 DASH for the STASH investor education and protection
program and contest conducted
by the Investor Protection Institute (IPI) and state securities agencies.
Protecting major transfers to persons, spending on health and education and
other spending such as that for Aboriginal
programs, research and development, and assuming you won't revisit defense and international assistance, then to find an additional $ 8 to $ 11 billion
by 2015 - 16 would require major cuts
in labor market
programs, spending on the homeless, infrastructure
programs, and last, but certainly not least, government personnel costs.
(a) Schedule 2.7 (a) of the Disclosure Schedule contains a list setting forth each employee benefit plan,
program, policy or arrangement (including any «employee benefit plan» as defined
in Section 3 (3) of the Employee Retirement Income Security Act of 1974, as amended («ERISA»)(«ERISA Plan»)-RRB-, including, without limitation, employee pension benefit plans, as defined
in Section 3 (2) of ERISA, multi-employer plans, as defined
in Section 3 (37) of ERISA, employee welfare benefit plans, as defined
in Section 3 (1) of ERISA, deferred compensation plans, stock option plans, bonus plans, stock purchase plans, fringe benefit plans, life, hospitalization, disability and
other insurance plans, severance or termination pay plans and policies, sick pay plans and vacation plans or arrangements, whether or not an ERISA Plan (including any funding mechanism therefore now
in effect or required
in the future as a result of the transactions contemplated
by this Agreement or otherwise), whether formal or informal, oral or written, under which (i) any current or former employee, director or individual consultant of the Company (collectively, the «Company Employees») has any present or future right to benefits and which are contributed to, sponsored
by or maintained
by the Company or (ii) the Company or any ERISA Affiliate (as hereinafter defined) has had, has or may have any actual or contingent present or future liability or obligation.
Within
program expenses, major transfers to persons were up $ 1.1 billion, primarily due to higher old age security payments, reflecting an increase
in the number of recipients and higher inflation, as benefits are indexed to quarterly changes
in the consumer price index, major transfers to
other levels of government were up $ 0.6 billion, reflecting legislative increases; while direct
program expenses declined
by $ 0.2 billion, as lower «
other transfer» payments more than offset increases
in departmental / agency operating costs.
Information about transfer bonuses received under the Relocation
Program in 2007
by John G. Stumpf and Carrie L. Tolstedt, each of whom is a named executive, appears on page 52 of this proxy statement
in the Perquisites table included
in footnote (8) to column (i), «All
Other Compensation»
in the Summary Compensation Table.
However, a budget deficit that takes the form of transfer payments to banks, as
in the case of the post-September 2008 bank bailout, the Federal Reserve's $ 2 trillion
in cash - for - trash financial swaps and the $ 700 billion QE2 credit creation
by the Federal Reserve to lend to banks at 0.25 % interest
in 2011, has a different effect from deficits that reflect social spending
programs, Social Security and Medicare, public infrastructure investment or the purchase of
other goods and services.
First,
by the end of 2014, following the large - scale asset purchase
programs, the Federal Reserve balance sheet was funded
by about $ 3.1 trillion
in liabilities
other than Federal Reserve notes, which were mostly
in the form of reserves
in excess of the amount banks were required to hold;
in contrast, there were only $ 64 billion of non-Federal Reserve note liabilities
in June 2007, of which only about $ 2 billion were excess reserves.
Program expenses were lowered by $ 5.4 billion in that Update, with all three major components contributing to the decline: major transfers to persons down $ 1.8 billion, primarily due to lower employment insurance benefits; major transfers to other levels of government, down $ 1.4 billion, primarily reflecting the recovery of the sales tax harmonization transitional payment from British Columbia; and direct program expenses, down $ 2.2 billion, due to lower other tra
Program expenses were lowered
by $ 5.4 billion
in that Update, with all three major components contributing to the decline: major transfers to persons down $ 1.8 billion, primarily due to lower employment insurance benefits; major transfers to
other levels of government, down $ 1.4 billion, primarily reflecting the recovery of the sales tax harmonization transitional payment from British Columbia; and direct
program expenses, down $ 2.2 billion, due to lower other tra
program expenses, down $ 2.2 billion, due to lower
other transfers.
Any purchase of our Class A common stock
in this offering through the underwriter administering
program will be at the same initial public offering price, and at the same time, as any
other purchases
in this offering, including purchases
by institutions and
other large investors.
These efficiency gains
in the SR&ED
Program could be tied into a common service platform for federal business innovation support
programs such as the IRIC proposed
by the Jenkins report and redirected to
other support
programs for innovation.
Senate Health Committee Chairman Lamar Alexander and Sen. Susan Collins, Maine Republican, have partnered with Democrats on bills that would reel
in rate hikes
by resuming reimbursements for insurers who pick up low - income customers costs on the Obamacare exchanges and freeing up billions for a «reinsurance»
program that blunts the cost of customers with big claims, so
others don't have to pay more.
The following benefits are not subject to the HP Severance Policy, either because they have been previously earned or accrued
by the employee or because they are consistent with Company Practices: (i) compensation and benefits earned, accrued, deferred or otherwise provided for employment services rendered on or prior to the date of termination of employment pursuant to bonus, retirement, deferred compensation or
other benefit plans, e.g., 401 (k) plan distributions, payments pursuant to retirement plans, distributions under deferred compensation plans or payments for accrued benefits such as unused vacation days, and any amounts earned with respect to such compensation and benefits
in accordance with the terms of the applicable plan; (ii) payments of prorated portions of bonuses or prorated long - term incentive payments that are consistent with Company Practices; (iii) acceleration of the vesting of stock options, stock appreciation rights, restricted stock, restricted stock units or long - term cash incentives that is consistent with Company Practices; (iv) payments or benefits required to be provided
by law; and (v) benefits and perquisites provided
in accordance with the terms of any benefit plan,
program or arrangement sponsored
by HP or its affiliates that are consistent with Company Practices.
The project, which will generate enough electricity to power approximately 15,000 homes, will begin delivering power to SMUD
in support of its SolarShares
program and
other renewable energy goals
by early 2018.
Information about the transfer bonus received under the Relocation
Program in 2008
by our CEO appears on page 71 of this proxy statement
in the Perquisites table included
in footnote (7) to column (i), «All
Other Compensation»
in the Summary Compensation Table.
Expenses for
other direct
program expenses (excluding
other transfer payments) could be $ 2 billion higher than estimated
in Budget 2012, especially if the Government decides to book the shortfall
in the environmental liability as identified
by the Commissioner for the Environment and Sustainable Development.
At the time, CBC English television was
in a ratings slump, having been hammered
by government cutbacks, competition from
other channels and the Internet, as well as uninspired
programming.
It seems bizarre that the most reasonable understanding of why the 2008 bank crisis did not require a vast public subsidy for Wall Street occurred at Monday's Republican presidential debate on June 13,
by none
other than Congressional Tea Party leader Michele Bachmann — who had boasted
in a Wall Street Journal interview two days earlier, on Saturday, that she voted against the Troubled Asset Relief
Program (TARP) «both times.»
I enjoyed
other entries that stressed the importance of direct job creation
programs, which make a lot of sense, especially
in disadvantaged communities that won't be reached
by full employment.
Password keeper
programs work
by storing passwords and any
other confidential information (e.g. social security number, credit card information, account numbers)
in an encrypted database that no one besides you has access to see (not even the password keeper companies).
If an Award expires or becomes unexercisable without having been exercised
in full, is surrendered pursuant to an Exchange
Program, or, with respect to Restricted Stock, Restricted Stock Units, Performance Units or Performance Shares, is forfeited to or repurchased
by the Company due to failure to vest, the unpurchased Shares (or for Awards
other than Options or Stock Appreciation Rights the forfeited or repurchased Shares), which were subject thereto will become available for future grant or sale under the Plan (unless the Plan has terminated).
With the objective of learning from the rich experiences and lessons that
other countries have gained from their own
programs,
in early 2016, the Asia Pacific Foundation of Canada announced a competitive policy research grant for research on best practices
by foreign SME export assistance
programs.
Many factors could cause BlackBerry's actual results, performance or achievements to differ materially from those expressed or implied
by the forward - looking statements, including, without limitation: BlackBerry's ability to enhance its current products and services, or develop new products and services
in a timely manner or at competitive prices, including risks related to new product introductions; risks related to BlackBerry's ability to mitigate the impact of the anticipated decline
in BlackBerry's infrastructure access fees on its consolidated revenue
by developing an integrated services and software offering; intense competition, rapid change and significant strategic alliances within BlackBerry's industry; BlackBerry's reliance on carrier partners and distributors; risks associated with BlackBerry's foreign operations, including risks related to recent political and economic developments
in Venezuela and the impact of foreign currency restrictions; risks relating to network disruptions and
other business interruptions, including costs, potential liabilities, lost revenues and reputational damage associated with service interruptions; risks related to BlackBerry's ability to implement and to realize the anticipated benefits of its CORE
program; BlackBerry's ability to maintain or increase its cash balance; security risks; BlackBerry's ability to attract and retain key personnel; risks related to intellectual property rights; BlackBerry's ability to expand and manage BlackBerry (R) World (TM); risks related to the collection, storage, transmission, use and disclosure of confidential and personal information;
Finally, when asked if she has seen any
programs developed
by other countries to support startups that Canada might learn from and adopt, she suggests that France is very effective
in its support.
Launched
in December 2014
by executive order, the myRA
program is a savings plan offered
by the US Treasury that's intended to encourage retirement saving among low - income individuals lacking employer - sponsored accounts or
other convenient saving options.
«Many investors expected a more lengthy FDA review process of the JCAR015 trial (and potentially
other CAR - T
programs) and feared that a higher - degree regulatory scrutiny could increase the development risk of CAR T cell,» Leerink Research said
in a note co-authored
by analysts Michael Schmidt, Ph.D., Jonathan Chang, Ph.D., and Varun Kumar, Ph.D. «While it may take several weeks to reopen all clinical sites of the ROCKET trial, we believe the trial shouldn't be delayed
by more than ~ 3 months.»
Many factors could cause BlackBerry's actual results, performance or achievements to differ materially from those expressed or implied
by the forward - looking statements, including, without limitation: BlackBerry's ability to enhance its current products and services, or develop new products and services
in a timely manner or at competitive prices, including risks related to new product introductions; risks related to BlackBerry's ability to mitigate the impact of the anticipated decline
in BlackBerry's infrastructure access fees on its consolidated revenue
by developing an integrated services and software offering; intense competition, rapid change and significant strategic alliances within BlackBerry's industry; BlackBerry's reliance on carrier partners and distributors; risks associated with BlackBerry's foreign operations, including risks related to recent political and economic developments
in Venezuela and the impact of foreign currency restrictions; risks relating to network disruptions and
other business interruptions, including costs, potential liabilities, lost revenues and reputational damage associated with service interruptions; risks related to BlackBerry's ability to implement and to realize the anticipated benefits of its CORE
program; BlackBerry's ability to maintain or increase its cash balance; security risks; BlackBerry's ability to attract and retain key personnel; risks related to intellectual property rights; BlackBerry's ability to expand and manage BlackBerry ® World ™; risks related to the collection, storage, transmission, use and disclosure of confidential and personal information; BlackBerry's ability to manage inventory and asset risk; BlackBerry's reliance on suppliers of functional components for its products and risks relating to its supply chain; BlackBerry's ability to obtain rights to use software or components supplied
by third parties; BlackBerry's ability to successfully maintain and enhance its brand; risks related to government regulations, including regulations relating to encryption technology; BlackBerry's ability to continue to adapt to recent board and management changes and headcount reductions; reliance on strategic alliances with third - party network infrastructure developers, software platform vendors and service platform vendors; BlackBerry's reliance on third - party manufacturers; potential defects and vulnerabilities
in BlackBerry's products; risks related to litigation, including litigation claims arising from BlackBerry's practice of providing forward - looking guidance; potential charges relating to the impairment of intangible assets recorded on BlackBerry's balance sheet; risks as a result of actions of activist shareholders; government regulation of wireless spectrum and radio frequencies; risks related to economic and geopolitical conditions; risks associated with acquisitions; foreign exchange risks; and difficulties
in forecasting BlackBerry's financial results given the rapid technological changes, evolving industry standards, intense competition and short product life cycles that characterize the wireless communications industry.
eBay Partner Network, eBay's
in - house affiliate
program, enables publishers with resources to monetize their websites, social pages, mobile apps and
other online properties
by driving high - quality traffic to eBay.